These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 12226740)
1. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer. Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740 [TBL] [Abstract][Full Text] [Related]
2. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma. Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621 [TBL] [Abstract][Full Text] [Related]
3. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression. Huang H; Li F; Gordon JR; Xiang J Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823 [TBL] [Abstract][Full Text] [Related]
4. Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo. Dohlsten M; Hansson J; Ohlsson L; Litton M; Kalland T Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9791-5. PubMed ID: 7568219 [TBL] [Abstract][Full Text] [Related]
5. Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model. Sundstedt A; Celander M; Eriksson H; Törngren M; Hedlund G J Immunother; 2012 May; 35(4):344-53. PubMed ID: 22495392 [TBL] [Abstract][Full Text] [Related]
6. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects. Sundstedt A; Celander M; Hedlund G Int Immunopharmacol; 2008 Mar; 8(3):442-52. PubMed ID: 18279798 [TBL] [Abstract][Full Text] [Related]
7. Immune response during tumor therapy with antibody-superantigen fusion proteins. Rosendahl A; Hansson J; Sundstedt A; Kalland T; Dohlsten M Int J Cancer; 1996 Sep; 68(1):109-13. PubMed ID: 8895549 [TBL] [Abstract][Full Text] [Related]
8. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects. Sundstedt A; Celander M; Ohman MW; Forsberg G; Hedlund G Int Immunopharmacol; 2009 Aug; 9(9):1063-70. PubMed ID: 19410661 [TBL] [Abstract][Full Text] [Related]
10. Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100. Xia DJ; Zhang WP; Zheng S; Wang J; Pan JP; Wang Q; Zhang LH; Hamada H; Cao X Gene Ther; 2002 May; 9(9):592-601. PubMed ID: 11973635 [TBL] [Abstract][Full Text] [Related]
11. Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens. Rosendahl A; Kristensson K; Hansson J; Riesbeck K; Kalland T; Dohlsten M J Immunol; 1998 Jun; 160(11):5309-13. PubMed ID: 9605129 [TBL] [Abstract][Full Text] [Related]
12. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses. Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma. Ju DW; Tao Q; Cheng DS; Zhang W; Zhang M; Hamada H; Cao X Gene Ther; 2000 Feb; 7(4):329-38. PubMed ID: 10694814 [TBL] [Abstract][Full Text] [Related]
14. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide]. Zhang W; He L; Cao X Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032 [TBL] [Abstract][Full Text] [Related]
15. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma. Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049 [TBL] [Abstract][Full Text] [Related]
17. Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism. Zhang J; Zhou Z; Wang C; Shen J; Zheng Y; Zhang L; Wang J; Xia D Cancer Immunol Immunother; 2011 Apr; 60(4):559-73. PubMed ID: 21240488 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response. Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; He L; Wang J; Cao X J Cancer Res Clin Oncol; 2001 Dec; 127(12):718-26. PubMed ID: 11768611 [TBL] [Abstract][Full Text] [Related]
19. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens. Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Ju DW; Yang Y; Tao Q; Song WG; He L; Chen G; Gu S; Ting CC; Cao X Gene Ther; 2000 Oct; 7(19):1672-9. PubMed ID: 11083476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]